Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Kaman Corp

Article Abstract:

Kaman Corp.'s aerospace business has had less business owing to this difficult economic environment. It retains a strong balance sheet and expects to have an average annual earnings growth over the next 3 - 5 years of 1 2%-14%.

Author: Sebastiano, Justin T.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Securities issued, listed, Securities, Aircraft industry, Company securities, Kaman Corp., KAMNA

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Keystone Automotive Industries Inc.

Article Abstract:

Keystone Automotive Industries Inc. has regained half of lost business from the insurance industry, its market share continuing to increase. Earnings, share-price, and sales are likely to advance out to 2006-2008.

Author: Sebastiano, Justin T.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Market share, Evaluation, Automobile industry, Company market share, Rankings, Keystone Automotive Industries Inc., KEYS

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Finance, Company investment, Investments, Statistics, Company sales and earnings, Company earnings/profit, Company business forecast/projection, Company forecasts
Similar abstracts:
  • Abstracts: SBC Communications Inc. Dycom Industries Inc.. Citizens Communications
  • Abstracts: Borgwarner Inc. Valmont Industries Inc
  • Abstracts: Gentex Corp. Gentex Corporation. Centex Corp
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.